Search - tctmd.com

Displaying 441 - 460 of 988

Sort: Relevancy | Date

News Conference News ESC 2013

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Caitlin E. Cox

September 01, 2013

News Conference News ESC 2013

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

Yael L. Maxwell

September 01, 2013

News Daily News

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

August 30, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Yael L. Maxwell

August 23, 2013

Presentation

Prasugrel vs. Clopidogrel for Patients with Unstable Angina or NSTEMI With or Without Angiography

Presenter: Stephen D. Wiviott

August 20, 2013

News Daily News

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

Yael L. Maxwell

August 19, 2013

News Daily News

La Administración Upstream de Eptifibatida se asoció a Mejores Resultados en Pacientes PCI

Yael L. Maxwell

August 19, 2013

News Daily News

Un Estudio Analiza las Diferencias en los Resultados PCI en Hospitales Universitarios frente a No Universitarios

Yael L. Maxwell

August 12, 2013

News Daily News

Study Looks at Differences in PCI Outcomes at Teaching vs. Non-Teaching Hospitals

Yael L. Maxwell

August 12, 2013

News Daily News

PLATO: Ticagrelor Lowers Stent Thrombosis vs. Clopidogrel Across the Board in ACS

Caitlin E. Cox

August 12, 2013

News Daily News

PLATO: En Líneas Generales, el Ticagrelor Reduce la Trombosis del Stent frente al Clopidogrel en el Tratamiento del SCA

Caitlin E. Cox

August 12, 2013

News Daily News

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

L.A. McKeown

August 12, 2013

News Daily News

No hay un Mayor Riesgo de Mortalidad para Pacientes SLF con Reactividad Alta al Clopidogrel

L.A. McKeown

August 12, 2013

News Daily News

El Cilostazol Adicional Reduce la Reestenosis en Pacientes de Alto Riesgo que recibieron un SLF

August 08, 2013

News Daily News

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

August 08, 2013

News Daily News

Staged Stenting Best for Patients with Carotid Disease Prior to Heart Surgery

Caitlin E. Cox

August 05, 2013

News Daily News

La Implantación de un Stent por Sesiones es lo Mejor para Pacientes con Enfermedad Carotídea antes de la Cirugía Cardíaca

Caitlin E. Cox

August 05, 2013

Presentation

Stent Thrombosis with Ticagrelor vs. Clopidogrel in Patients with Acute Coronary Syndromes

Presenter: Philippe Gabriel Steg

August 02, 2013

Advertisement

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Prasugrel vs. Clopidogrel for Patients with Unstable Angina or NSTEMI With or Without Angiography

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

La Administración Upstream de Eptifibatida se asoció a Mejores Resultados en Pacientes PCI

Un Estudio Analiza las Diferencias en los Resultados PCI en Hospitales Universitarios frente a No Universitarios

Study Looks at Differences in PCI Outcomes at Teaching vs. Non-Teaching Hospitals

PLATO: Ticagrelor Lowers Stent Thrombosis vs. Clopidogrel Across the Board in ACS

PLATO: En Líneas Generales, el Ticagrelor Reduce la Trombosis del Stent frente al Clopidogrel en el Tratamiento del SCA

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

No hay un Mayor Riesgo de Mortalidad para Pacientes SLF con Reactividad Alta al Clopidogrel

El Cilostazol Adicional Reduce la Reestenosis en Pacientes de Alto Riesgo que recibieron un SLF

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

Staged Stenting Best for Patients with Carotid Disease Prior to Heart Surgery

La Implantación de un Stent por Sesiones es lo Mejor para Pacientes con Enfermedad Carotídea antes de la Cirugía Cardíaca

Stent Thrombosis with Ticagrelor vs. Clopidogrel in Patients with Acute Coronary Syndromes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content